Peptilogics
Peptilogics is dedicated to revolutionizing the discovery process for novel peptide therapeutics aimed at treating serious and life-threatening diseases. By leveraging the potential of peptide biology and advanced machine learning techniques, the company is transforming drug design and development, focusing on precision engineering to create next-generation medicines.
Peptilogics
2681 Sidney Street, Pittsburgh, PA 15203
Patents
Generating anti-infective design spaces for selecting drug candidates
2024-09-10 • US-12087404-B2
View DetailsMethods and apparatuses for generating peptides by synthesizing a portion of a design space to identify peptides having non-canonical amino acids
2024-06-11 • US-12006541-B2
View DetailsGenerating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates
2024-04-23 • US-11967400-B2
View DetailsGenerating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates
2023-12-19 • US-11848076-B2
View DetailsMethods and apparatuses for a unified artificial intelligence platform to synthesize diverse sets of peptides and peptidomimetics
2023-02-21 • US-11587643-B2
View DetailsMethods and apparatuses for generating peptides by synthesizing a portion of a design space to identify peptides having non-canonical amino acids
2022-11-29 • US-11512345-B1
View DetailsWhat We Do
An investigational antibiotic peptide candidate for the treatment of periprosthetic joint infection (PJI), demonstrating potent in vitro and nonclinical activity with an acceptable safety profile in Phase I studies.